...
机译:改善药代动力学性能的氘代VISMODEGIB的设计,合成及生物学评价
State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy;
State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy;
State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy;
State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy;
Frontier Institute of Science and Technology Xi’an Jiaotong University;
Chengdu University Sichuan Industrial Institute of Antibiotics;
State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy;
Vismodegib; Hedgehog signaling pathway; Basal cell carcinoma; Deuterated drug; Deuterium-hydrogen replacement; Pharmacokinetic properties;
机译:改善药代动力学性能的氘代VISMODEGIB的设计,合成及生物学评价
机译:氘代替诺扎尼改善药代动力学的设计,合成及生物学评价
机译:具有改进的药代动力学谱的氘化奥氟丁胺的设计,合成和生物学评价
机译:评价绵羊高分子透明质酸钠基质中β-TCP骨替代物的生物组织响应以改善处理性能
机译:设计和合成的分子探针,可调节细胞膜的渗透性:I.设计,合成和生物评价作为抗HIV-1整合酶抑制剂的新型菊苣酸类似物。二。针对膜雌激素受体的新型雌二醇类似物的设计,合成和生物学评估。
机译:氘代苯并吡喃衍生物的合成具有改善的药代动力学特性的选择性COX-2抑制剂
机译:氘化的催产素:在5-天冬酰胺位置上氘化的脱氨基-毒素的结晶类似物的合成和生物学性质*